Upstream Bio (UPB) Other Working Capital Changes (2023 - 2026)
Upstream Bio (UPB) posted quarterly Other Working Capital Changes of -$155000.0 for Q1 2026, down 15.67% year-over-year from -$183805.3 in Q1 2025, and down 3.33% quarter-over-quarter from -$150000.0 in Q4 2025.
Analysis
Upstream Bio (UPB) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Upstream Bio's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$155000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 15.67% year-over-year to -$155000.0; the TTM figure through Mar 2026 stood at -$586000.0 (down 139.18% YoY), while the FY2025 annual figure was -$565000.0, down 324.81% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$155000.0, down from -$150000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $13.7 million in Q1 2025, with the low at -$7.8 million in Q3 2025.
- The 4-year median for Other Working Capital Changes is $1.8 million (2024), against an average of $1.9 million.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes slumped 847.37% in 2025, then declined 15.67% in 2026.
- Upstream Bio's Other Working Capital Changes stood at -$20000.0 in 2023, then slumped by 435.0% to -$107000.0 in 2024, then tumbled by 40.19% to -$150000.0 in 2025, then fell by 3.33% to -$155000.0 in 2026.
- Business Quant data shows UPB's Other Working Capital Changes at -$155000.0 in Q1 2026, -$150000.0 in Q4 2025, and -$142000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Upstream Bio | 327.95 Mn | 327.95 Mn | -3.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.14 Mn |
| Jun 30, 2026 | -3.14 Mn |
| Mar 31, 2026 | 11.05 Mn |
| Mar 31, 2026 | 11.05 Mn |
| Dec 31, 2025 | -6.29 Mn |
| Dec 31, 2025 | -6.29 Mn |
| Sep 30, 2025 | -7.85 Mn |
| Sep 30, 2025 | -7.85 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 13.75 Mn |
| Mar 31, 2025 | 13.75 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | -710,000.00 |
| Sep 30, 2024 | -710,000.00 |
| Jun 30, 2024 | -2.07 Mn |
| Jun 30, 2024 | -2.07 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |